Published DateClear

Start Date

End Date

Category

• Products1
• Research1

Organizations

• Bausch + Lomb73
• Eyes On Eyecare56
• Alcon, Inc.51
• American Optometric Association42
• Harrow34
• Glaukos30
• Topcon Healthcare26
• Regeneron25
• Coopervision22
• Aldeyra Therapeutics21

Tags

• Injections2
• Products2
• DME1
• Fda Approval1
• Clinical Trials1
• Macula1
• Retinal Vein Occlusion (rvo)1

• Organizations: Roche✕

Clear all

Research

4-year data shows Vabymso delivers lasting DME results with fewer injections

Open-label extension study demonstrates long-term safety, efficacy, and tolerability of faricimab in DME patients.

Products

FDA approves extended Vabysmo label for macular edema following RVO

Updated labeling enables IVT treatment beyond 6 months, intended to enable more flexible and tailored treatment plans.